21617-19-6

Basic information

• Product Name: 3-[(4-chlorophenyl)amino]propanoic acid
• Synonyms: 3-[(4-chlorophenyl)amino]propanoic acid;B-ALANINE, N-(4-CHLOROPHENYL)-;N-(4-CHLOROPHENYL)-B-ALANINE;OTAVA-BB 1142585;UKRORGSYN-BB BBV-215961;beta-Alanine, N-(4-chlorophenyl)-;3-(4-chloroanilino)propanoic acid
• CAS NO: 21617-19-6
• Molecular Formula: C₉H₁₀ClNO₂
• Molecular Weight: 199.64
• Mol File: 21617-19-6.mol
• Article Data: 5

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 3-[(4-chlorophenyl)amino]propanoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 3-[(4-chlorophenyl)amino]propanoic acid(21617-19-6)
• EPA Substance Registry System: 3-[(4-chlorophenyl)amino]propanoic acid(21617-19-6)

Safety Data

• Hazardous Substances Data: 21617-19-6(Hazardous Substances Data)

Usage

General Description

3-[(4-chlorophenyl)amino]propanoic acid, also known as carprofen, is a nonsteroidal anti-inflammatory drug (NSAID) used for the relief of pain and inflammation in dogs and cats. It works by inhibiting the production of prostaglandins, which are chemicals that are responsible for pain and inflammation in the body. Carprofen is commonly prescribed by veterinarians to manage arthritis and other musculoskeletal conditions in pets. It is available in various forms, such as tablets, chewable tablets, and injectable solutions, and is generally well-tolerated with few side effects when used as directed by a veterinarian. However, it should be used with caution in animals with pre-existing kidney or liver disease, as well as in those with a history of gastrointestinal ulcers.

Upstream product

• 57-57-8 β-Propiolactone 
• 106-47-8 4-chloro-aniline 
• 41833-57-2 3-(4-chlorophenylamino)propanenitrile 
• 79-10-7 acrylic acid 
• 76227-93-5 ethyl 3-((4-chlorophenyl)amino)propanoate 

Relevant articles and documents

Method for preparing 1-(4-chlorphenyl)-pyrazolidine-3-one

The invention relates to the field of bactericide synthesis, and discloses a method for preparing 1-(4-chlorphenyl)-pyrazolidine-3-one. The method comprises the following steps: 1) reacting parachloroaniline with acrylic acid to obtain an addition reactio

Fused, Tricyclic Sulfonamide Inhibitors of Gamma Secretase

The invention provides compounds of formula I: or pharmaceutically salts thereof where R1, R2, and the A, B, and C-rings are as defined herein. Compounds of formula I are useful in treating or preventing cognitive disorders, such as Alzheimer's disease. The invention also encompasses pharmaceutical compositions comprising compounds or salts of formula I, methods of preparing the desired compounds, and methods of treating cognitive disorders, such as Alzheimer's disease, using the compounds or salts of formula I.

Pyridocarbazole derivatives having cGMP-PDE inhibitory activity

PCT No. PCT/JP97/01829 Sec. 371 Date Jan. 29, 1998 Sec. 102(e) Date Jan. 29, 1998 PCT Filed May 29, 1997 PCT Pub. No. WO97/45427 PCT Pub. Date Dec. 4, 1997The invention relates to novel pyridocarbazole derivatives having highly selective action in inhibiting cyclic GMP-phosphodiesterase (hereinafter abbreviated as cGMP-PDE), processes for producing such derivatives, agents containing at least one of such derivatives as an active ingredient for preventing and/or treating pulmonary hypertension, ischemic heart diseases or diseases against which the cGMP-PDE inhibitory action is effective, and intermediates useful for the production of pyridocarbazole derivatives.